| 变量 | 例数N/% | ||
| 年龄 |
| ||
| >50 | 70 (50.0) | ||
| ≤50 | 70 (50.0) | ||
| 月经 |
| ||
| 绝经前 | 62 (44.3) | ||
| 绝经后 | 78 (55.7) | ||
| 病理类型 |
| ||
| 浸润性癌 | 133 (95.0) | ||
| 其余 | 7 (5.0) | ||
| 组织学分级 |
| ||
| G1~G2 | 96 (68.6) | ||
| G3 | 44 (31.4) | ||
| 淋巴结情况 |
| ||
| 阴性 | 68 (48.6) | ||
| 阳性 | 72 (51.4) | ||
| 临床分期 |
| ||
| Ⅰ~Ⅱ期 | 91 (65.0) | ||
| Ⅲ期 | 49 (35.0) | ||
| 激素受体 |
| ||
| 阳性 | 89 (63.6) | ||
| 阴性 | 51 (36.4) | ||
| HER-2 |
| ||
| 阳性 | 33 (23.6) | ||
| 阴性 | 107 (76.4) | ||
| 分型 |
| ||
| Luminal A | 51 (36.4) | ||
| Luminal B | 27 (19.3) | ||
| HER-2阳性 | 31 (22.1) | ||
| 三阴性 | 31 (22.1) | ||
| Kit-67 |
| ||
| ≤14% | 45 (32.1) | ||
| >14% | 195 (67.9) | ||
| 化疗方案 |
| ||
| 蒽环 | 96 (68.6) | ||
| 去蒽环 | 44 (31.4) | ||
| MP分级 |
| ||
| 1 | 7 (5) | ||
| 2 | 40 (28.6) | ||
| 3 | 58 (41.4) | ||
| 4 | 14 (10.0) | ||
| 5 | 21 (15.0) | ||
| PCR |
| ||
| 是 | 21 (15.0) | ||
| 否 | 119 (85.0) | ||
| TILs |
| ||
| ≤25% | 110 (78.6) | ||
| >25% | 30 (21.4) | ||